Enter your login e-mail to the account
Search
- Pacient v remisii po onkologickej liečbe môže byť sledovaný všeobecným lekárom
MUDr. Adriana Šimková, PhD. , MUDr. Mária Rečková, PhD., prof. MUDr. Stanislav Špánik, CSc., prof. MUDr. Michal Mego, DrSC., MUDr. Branislav Bystrický, PhD., MPH
(3/2023, Information & comments )
- Postradiation dermatitis: Prevention and treatment options
MUDr. Marcela Vojčiaková, MUDr. Branislav Bystrický, PhD., MPH, MUDr. Filip Kohútek, PhD.
(5/2024, Review articles ) - Správa z Bratislavských onkologických dní, LX. ročník
MUDr. Branislav Bystrický, PhD., MPH
(6/2023, Events ) - Sacituzumab govitekan – drug profile
MUDr. Branislav Bystrický, PhD., MPH
(3/2023, Drugs & drug classes ) - Systemic treatment of advanced pancreatic cancer and the role of nanoliposomal irinotecan in it
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(3/2023, Main topic ) - Pacient v remisii po onkologickej liečbe môže byť sledovaný všeobecným lekárom
MUDr. Adriana Šimková, PhD. , MUDr. Mária Rečková, PhD., prof. MUDr. Stanislav Špánik, CSc., prof. MUDr. Michal Mego, DrSC., MUDr. Branislav Bystrický, PhD., MPH
(1/2023, Information & comments ) - Bratislavské onkologické dni, 59. ročník 12. – 14. 10. 2022 hotel Saffron, Bratislava
MUDr. Branislav Bystrický, PhD., MPH
(6/2022, Events ) - New trends in the treatment of non-small cell renal cell carcinoma
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(4/2022, Main topic ) - Optimal management of patients with breast cancer after progression on CDK4/6 inhibitors.
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(2/2022, Main topic ) - The role of immuotherapy in the treatment of colorectal cancer
MUDr. Branislav Bystrický, PhD., MPH
(1/2022, Main topic ) - Gynekologické malignity
MUDr. Branislav Bystrický, PhD, MPH
(4/2021, Editorial ) - The vaccination against COVID-19 in cancer patients
MUDr. Branislav Bystrický, PhD., MPH
(2/2021, Main topic ) - Nanoliposomal irinotecan – drug profile
MUDr. Branislav Bystrický, PhD., MPH
(1/2021, Drugs & drug classes ) - Essential principes of chemotherapy for stage II and III colon cancer
MUDr. Branislav Bystrický, PhD., MPH
(4/2020, Main topic ) - Anti-EGFR treatment in colorectal cancer – what is ist role today and in the future?
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(5/2019, Review articles ) - Rare cancers of upper gastrointestinal tract
MUDr. Branislav Bystrický, PhD., MPH, MUDr. Silvia Zavřelová, MUDr. Tomáš Sedláček
(4/2019, Main topic ) - Management of adverse reactions in treatment with mTOR and CDK4/6 inhibitors
MUDr. Branislav Bystrický, PhD., MPH
(2/2019, Review articles ) - Prehľad siete onkologických pracovísk na Slovensku – stav k 31. marcu 2018
prof. MUDr. Michal Mego, DrSC., doc. MUDr. Jozef Mardiak, CSc., MUDr. Marián Streško, PhD., MUDr. Branislav Bystrický, PhD., MPH, MUDr. Richard Hrubý, PhD., MUDr. Juraj Detvay, PhD., MPH, doc. MUDr.Peter Beržinec, CSc., MUDr. Vladimír Malec, PhD., MUDr. Juraj Beniak, MUDr. Igor Andrašina, CSc., MUDr. Tomáš Šálek
(2/2018, Information & comments ) - Pancreatic and biliary cancer
MUDr. Filip Kohútek, PhD., MUDr. Tomáš Sedláček, MUDr. Branislav Bystrický, PhD., MPH
(1/2018, Review articles ) - Choosing Wisely alebo Vyberajme liečbu s rozumom
MUDr. Branislav Bystrický
(6/2017, Information & comments ) - Malignancies of gastrointestinal tract in geriatric patients
MUDr. Branislav Bystrický
(3/2017, Main topic ) - Patient´s potential in evaluation of oncologic treatment benefit in the context of quality of life in patients with breast cancer
Doc. MUDr. Ján Bielik, CSc., PhDr. Iveta Matišáková, PHD., Mgr. Renáta Kormancová, MUDr. Branislav Bystrický, RNDr. Vladimír Meluš, PhD., MPH
(2/2017, Main topic ) - Palbociclib in the treatment of advanced breast cancer
MUDr. Branislav Bystrický
(1/2017, Drugs & drug classes ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Follow-up after treatment in patients with malignant disease
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Andrej Rosík, MUDr. Miroslava Stratená, MUDr. Mário Bôžik
(3/2015, Main topic ) - Treatment of inicially metastatic small-cell lung cancer
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, doc. MUDr. Mária Tamášová, CSc.
(5/2013, Review articles ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic )
- The prophylaxis of venous thromboembolism and metastatic breast cancer
prof. MUDr. Peter Kubisz, DrSc., MUDr. Juraj Chudej, PhD., MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(2/2016, Original articles & Case reports )